Latest GM & Biosafety Resources

Oxitec’s failed GM mosquito releases worldwide: Forewarnings for Africa and the Target Malaria project

A decade ago, genetically modified (GM) mosquitoes were first released globally, in the Cayman Islands, by UK-based company Oxitec. Further releases followed in Malaysia, Panama and Brazil. In a public relations whitewash, Oxitec has repeatedly claimed that the experiments successfully wiped out nearly 90% of the Aedes aegypti mosquito population, which is one of the […]

READ

Objection to commercial release of MON87460 X NK603 X MON89034 (triple stacked involving drought tolerant maize trait)

In this objection, ACB raises numerous concerns with the application by Monsanto for the commercial release of the triple stacked event. Drought tolerance is a highly complex genetic trait that cannot be addressed by single gene insertions, as shown by the lack of data backing up the applicant’s claim that this GM variety shows “improvements […]

READ

ACB’s objection to Monsanto’s commodity clearance application for Smartstax

On 20 April, Business Day carried a public notice of Monsanto’s application to the South African GMO registrar for permission to import Smartstax maize, arguably the world’s most controversial and risky commercially grown GMO. While the majority of commercially grown genetically engineered crops contain at most 3 foreign genes, Smartstax contains eight, 6 of which […]

READ